Pharmacie Themlin: what changed
Pharmacie Themlin
Largest movements
- Cash -€38,557
down €38,557 (-71.9%), from €53,594 to €15,036
mainly Net result for the year (-€31,378) and Debts after one year (-€18,966)
- Stocks and contracts -€16,583
down €16,583 (-18.5%), from €89,744 to €73,161
- Deferred charges and accrued income +€14,546
new in 2025: €14,546
- Tangible fixed assets -€11,398
down €11,398 (-3.8%), from €297,913 to €286,516
of which Land and buildings: -€12,851
- Receivables within one year +€8,600
up €8,600 (+13.7%), from €62,732 to €71,333
of which Trade receivables: +€9,487
- Profit (loss) carried forward -€31,378
down €31,378 (-31.5%), from €99,511 to €68,133
- Debts after one year -€18,966
down €18,966 (-13.8%), from €137,324 to €118,358
- Trade debts +€5,557
up €5,557 (+8.2%), from €67,734 to €73,291
- Gross operating margin -€38,674
down €38,674 (-22.4%), from €172,750 to €134,076
- Staff costs +€22,657
up €22,657 (+21.3%), from €106,144 to €128,801
- Taxes -€10,687
down €10,687 (-97.6%), from €10,954 to €267
- Write-downs +€6,591
new in 2025: €6,591
- Other operating charges -€4,158
down €4,158 (-55.9%), from €7,436 to €3,279
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €511,441 | €468,049 | -€43,392 | -8.5% |
| Fixed assets | 21/28 | €305,371 | €293,973 | -€11,398 | -3.7% |
| Intangible fixed assets | 21 | €0 | €0 | = | |
| Tangible fixed assets | 22/27 | €297,913 | €286,516 | -€11,398 | -3.8% |
| Land and buildings | 22 | €267,647 | €254,797 | -€12,851 | -4.8% |
| Plant, machinery and equipment | 23 | €30,266 | €31,719 | +€1,453 | +4.8% |
| Furniture and vehicles | 24 | €0 | €0 | = | |
| Financial fixed assets | 28 | €7,458 | €7,458 | = | 0.0% |
| Current assets | 29/58 | €206,070 | €174,076 | -€31,994 | -15.5% |
| Stocks and contracts in progress | 3 | €89,744 | €73,161 | -€16,583 | -18.5% |
| Stocks | 30/36 | €89,744 | €73,161 | -€16,583 | -18.5% |
| Amounts receivable within one year | 40/41 | €62,732 | €71,333 | +€8,600 | +13.7% |
| Trade receivables | 40 | €59,937 | €69,424 | +€9,487 | +15.8% |
| Other amounts receivable | 41 | €2,796 | €1,909 | -€887 | -31.7% |
| Cash at bank and in hand | 54/58 | €53,594 | €15,036 | -€38,557 | -71.9% |
| Deferred charges and accrued income | 490/1 | - | €14,546 | +€14,546 | |
| Total equity and liabilities | 10/49 | €511,441 | €468,049 | -€43,392 | -8.5% |
| Equity | 10/15 | €118,111 | €86,733 | -€31,378 | -26.6% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Profit (loss) carried forward | 14 | €99,511 | €68,133 | -€31,378 | -31.5% |
| Amounts payable | 17/49 | €393,330 | €381,317 | -€12,014 | -3.1% |
| Amounts payable after more than one year | 17 | €137,324 | €118,358 | -€18,966 | -13.8% |
| Financial debts | 170/4 | €137,324 | €118,358 | -€18,966 | -13.8% |
| Amounts payable within one year | 42/48 | €256,007 | €262,959 | +€6,953 | +2.7% |
| Current portion of amounts payable after more than one year | 42 | €22,544 | €24,412 | +€1,868 | +8.3% |
| Trade debts | 44 | €67,734 | €73,291 | +€5,557 | +8.2% |
| Suppliers | 440/4 | €67,734 | €73,291 | +€5,557 | +8.2% |
| Taxes, remuneration and social security | 45 | €18,249 | €18,631 | +€382 | +2.1% |
| Taxes | 450/3 | €7,203 | €3,392 | -€3,811 | -52.9% |
| Remuneration and social security | 454/9 | €11,046 | €15,239 | +€4,192 | +38.0% |
| Other amounts payable | 47/48 | €147,479 | €146,626 | -€854 | -0.6% |
| Remuneration, social security and pensions | 62 | €106,144 | €128,801 | +€22,657 | +21.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €19,566 | €21,284 | +€1,719 | +8.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €6,591 | +€6,591 | |
| Other operating charges | 640/8 | €7,436 | €3,279 | -€4,158 | -55.9% |
| Gross operating margin | 9900 | €172,750 | €134,076 | -€38,674 | -22.4% |
| Operating profit (loss) | 9901 | €39,604 | -€25,879 | -€65,483 | |
| Financial income | 75/76B | €26 | €24 | -€3 | -10.1% |
| Recurring financial income | 75 | €26 | €24 | -€3 | -10.1% |
| Financial charges | 65/66B | €2,122 | €5,255 | +€3,134 | +148% |
| Recurring financial charges | 65 | €2,122 | €5,255 | +€3,134 | +148% |
| Profit (loss) for the period before taxes | 9903 | €37,508 | -€31,111 | -€68,619 | |
| Income taxes | 67/77 | €10,954 | €267 | -€10,687 | -97.6% |
| Profit (loss) for the period | 9904 | €26,554 | -€31,378 | -€57,933 | |
| Profit (loss) for the period to be appropriated | 9905 | €26,554 | -€31,378 | -€57,933 |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 5 November 2026 via checked.be.